The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats

Transplantation

Volumn 65, Issue 9, 1998, Pages 1152-1158

  Merten, Steven ^a   Chen, Ju Chuan ^a   Ha, Hong ^a   Plain, Karren ^a   Boyd, Rochelle A ^a   Penny, Mark J ^a   Leenaerts, Peter ^a   Hall, Bruce M ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOPEROXIDASE STAINING; IMMUNOREGULATION; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; COMPLEMENT C6; CYTOKINES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; ISOANTIBODIES; RATS; RATS, INBRED STRAINS; RATS, MUTANT STRAINS; REFERENCE VALUES; RNA, MESSENGER; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0344015793     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805150-00002     Document Type: Article

References (28)

1. Hall BM, Dorsch S, Roser B. The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J Exp Med 1978; 148(4): 878.
2. Hall BM, Dorsch S, Roser B. The cellular basis of allograft rejection in vivo. II. The nature of memory cells mediating second set heart graft rejection. J Exp Med 1978; 148(4): 890.
3. Hall BM. Cells mediating allograft rejection: overview. Transplantation 1991; 51: 1141.
4. Brauer RB, Lam TT, Wang D, et al. Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograft. Transplantation 1995; 59(7): 1073.
5. Pearce NW, Spinelli A, Gurley KE, Dorsch SE, Hall BM. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells. J Immunol 1989; 143: 499.
6. Hall BM. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med 1985; 161: 123.
7. Baldwin WB, Priutt SK, Brauer RB, Daha MR, Sanfilippo F. Complement in organ transplantation. Transplantation 1995; 59(6): 797.
8. Davies A, Lachmann PJ. Membrane defence against complement lysis: the structure and biological properties of CD59. Immunol Res 1993; 12(3): 258.
9. Leventhal JR, Matas AJ, Sun LH, et al. The immunopathology of cardiac xenograft rejection in the guinea pig- to-rat model. Transplantation 1993; 56(1): 1.
10. Albert ED, Scholz D. Transplantation antigens and why they are so important. In: Wood K, ed. The handbook of transplant immunology. 1995: 55.
11. French ME. The early effects of alloantibody and complement on rat kidney allografts. Transplantation 1972; 13(5): 447.
12. Gracie JA, Bolton EM, Porteous C, Bradley JA. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med 1990; 172(6): 1547.
13. Morton AL, Bell EB, Bolton EM, et al. CD4+ T cell-mediated rejection of major histocompatability complex class I-disparate grafts: a role for alloantibody. Eur J Immunol 1993; 23: 2078.
14. Rosenberg AS, Mizuochi T, Singer A. Evidence for involvement of dual-junction T cells in rejection of MHC class I disparate skin grafts: assessment of MHC class I alloantigens as in vivo helper determinants. J Exp Med 1988; 168(1 ): 33.
15. Campos L, Naji A, Deli BC, et al. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59(2): 187.
16. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174(2): 493.
17. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173(1): 79.
18. Hall BM, de Saxe I, Dorsch SE. The cellular basis of allograft rejection in vivo. III. Restoration of first-set rejection of heart grafts by T helper cells in irradiated rats. Transplantation 1983; 36(6): 700.
19. Leenaerts PL, Stad RK, Hall BM, Van Damme BJ, Vanrenterghem Y, Daha MR. Hereditary C6 deficiency in a strain of PVG/c rats. Clin Exp Immunol 1994; 97(3): 478.
20. Schur P. Complement studies of sere and other biological fluids. Hum Pathol 1993; 14: 338.
21. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57(2): 225.
22. Chomczynski N, Sacchi P. Single step method for RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Blochem 1987; 162: 156.
23. Penny M, Boyd R, Hall B. Role of T cells in mediation of Heymann's nephritis. Kidney Int 1997; 51: 1059.
24. Trpkov K, Halloran P. Pathologic features of acute renal allograft rejection associated with donor-specific antibody: analysis using the Banff grading schema. Transplantation 1996; 61(11): 1586.
25. Morris P. Suppression of rejection of organ allografts by alloantibody. Immunol Rev 1980; 49: 93.
26. Batchelor J, Welsh K. Mechanisms of enhancement of kidney allograft survival. Br Med Bull 1976; 31: 113.
27. Hall B. Mechanisms of specific unresponsiveness to allografts. Transplant Proc 1984; 16: 938.
28. Brauer RB, Baldwin WM III, Ibrahim S, Sanfilippo F. The contribution of terminal complement components to acute and hyperacute allograft rejection n the rat. Transplantation 1995; 59(2): 288.